Kulicke & Soffa Appoints Jeff Richardson to its Board of Directors
SINGAPORE--(BUSINESS WIRE)--Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S" or the "Company") today announced the appointment of...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
KartRider Rush+ Surpasses 10 Million Global Downloads Within Two Weeks!
Nexon’s Thrilling Mobile Racer Adds Three New Tracks and New Character ‘Dino Ethen’ LOS ANGELES--(BUSINESS WIRE)--#kartracer--Let’s go full throttle! Today,...
TriLinc Global Impact Fund Makes Impact Investment in Latin America
TriLinc Global Impact Fund announced today that it recently approved a $3,250,000 term loan transaction, bringing total financing commitments as...
COVID-19 Case Study: Retailers Reactions in China 2020 – Lin Qingxuan, Nike, Meituan Dianping, JD.com, Alibaba, and Hema – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Retailer Reactions in China: Coronavirus (COVID-19) - Case Study" report has been added to ResearchAndMarkets.com's offering. This brief...
Impact of COVID-19 on the Retail Sector in China, 2020 – Consumer Behaviour and Purchasing Patterns on Food, Non-Food, Drinks and Personal Care – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Retail in China: Coronavirus (COVID-19) Country impact" report has been added to ResearchAndMarkets.com's offering. The Coronavirus (COVID-19) country...
Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
– Oral Presentations of the Phase 2 OPTIC Interim Analysis at the American Society of Clinical Oncology (ASCO) and the...
Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS
– Pevonedistat Combination Demonstrates the Potential to Double Complete Remissions and Improve Outcomes in HR-MDS, With Safety Profile Similar to...
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into...
MOGU Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
Live Video Broadcast Business (“LVB”) Maintains Robust Growth Momentum with GMV in the Fourth Quarter and Fiscal Year 2020 Increasing...
Indian OTT and Pay TV Market Analysis and Trajectory 2018-2025 – Netflix, Amazon Prime Video, Disney+, Apple TV+, Zee5 and More – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India OTT and Pay TV Forecasts" report has been added to ResearchAndMarkets.com's offering. This 36-page PDF report covers...
Renesas Electronics Announces Consolidated Forecasts for the Second Quarter and First Half of 2020
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts for...
Wipro Appoints Thierry Delaporte as CEO & Managing Director
EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)--#RishadPremji--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting...
Wipro Limited Appoints Deepak M Satwalekar to its Board
BANGALORE, India & EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--#DeepakSatwalekar--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting,...
Reveal Group is First and Only Partner to Achieve Blue Prism “Double Platinum” Capability Certification
Company Sets New Standard for Intelligent Automation Delivery Capabilities NEW YORK & SYDNEY--(BUSINESS WIRE)--#BluePrism--Reveal Group, a global leader in Robotic...
New data show first-line triplet regimen of pembrolizumab, Herzuma® (biosimilar trastuzumab) and chemotherapy are effective in treatment of HER2-positive advanced gastric cancer
Data from a phase Ib/II trial show a first-line triple combination therapy of pembrolizumab, Herzuma®(biosimilar trastuzumab) and chemotherapy was effective...
